US biotech Alnylam says it could file its first product in 2017, a rare disease drug using what has long promised to be a revolutionary approach, RNA interference. The company is one of a handful of ...

Elmos Semiconductor SE will present an extensive lineup of new semiconductor technologies at CES 2026, demonstrating how its innovations enhance vehicle efficiency, safety, comfort, sensing, and ...

Standard Chartered has launched a major health-focused wealth proposition through new strategic partnerships with Bupa Global and WHOOP, offering affluent clients a combined ecosystem of international ...